FCNKX
Price
$24.41
Change
+$0.33 (+1.37%)
Updated
Aug 12 closing price
Net Assets
173.37B
RGEBX
Price
$81.45
Change
+$1.12 (+1.39%)
Updated
Aug 12 closing price
Net Assets
324.88B
Interact to see
Advertisement

FCNKX vs RGEBX

Header iconFCNKX vs RGEBX Comparison
Open Charts FCNKX vs RGEBXBanner chart's image
Fidelity Contrafund K
Price$24.41
Change+$0.33 (+1.37%)
VolumeN/A
Net Assets173.37B
American Funds Growth Fund of Amer R2E
Price$81.45
Change+$1.12 (+1.39%)
VolumeN/A
Net Assets324.88B
FCNKX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FCNKX vs. RGEBX commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCNKX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 325B vs. FCNKX (173B). FCNKX pays higher dividends than RGEBX: FCNKX (0.10) vs RGEBX (0.00). FCNKX was incepted earlier than RGEBX: FCNKX (17 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FCNKX (0.56). RGEBX is a more actively managed with annual turnover of: 25.00 vs. FCNKX (18.00). FCNKX has a lower initial minimum investment than RGEBX: FCNKX (0) vs RGEBX (250). FCNKX annual gain was more profitable for investors over the last year : 22.68 vs. RGEBX (18.71). FCNKX return over 5 years is better than : 49.15 vs. RGEBX (40.58).
FCNKXRGEBXFCNKX / RGEBX
Total Expense Ratio0.561.0951%
Annual Report Gross Expense Ratio0.561.0951%
Fund Existence17 years11 years-
Gain YTD14.12314.012101%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets173B325B53%
Annual Yield % from dividends0.100.00-
Returns for 1 year22.6818.71121%
Returns for 3 years61.0640.73150%
Returns for 5 years49.1540.58121%
Returns for 10 years132.8080.20166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTKB4.030.24
+6.33%
Cytek Biosciences
DXC13.260.41
+3.19%
DXC Technology Company
EUDA2.590.07
+2.78%
EUDA Health Holdings Limited
THC170.483.85
+2.31%
Tenet Healthcare Corp
ARTL9.72-0.31
-3.09%
Artelo Biosciences Inc